Tadashi Hanabusa

780 total citations
20 papers, 619 citations indexed

About

Tadashi Hanabusa is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Tadashi Hanabusa has authored 20 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Tadashi Hanabusa's work include Pancreatic function and diabetes (11 papers), Diabetes Treatment and Management (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Tadashi Hanabusa is often cited by papers focused on Pancreatic function and diabetes (11 papers), Diabetes Treatment and Management (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Tadashi Hanabusa collaborates with scholars based in Japan and United States. Tadashi Hanabusa's co-authors include Kishio Nanjo, Tokio Sanke, Setsuya Sakagashira, Hiroto Furuta, Hideyuki Sasaki, Masahiro Nishi, Shinya Ohagi, Henry J. Hiddinga, Kayoko Tateishi and Norman L. Eberhardt and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Tadashi Hanabusa

18 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadashi Hanabusa Japan 12 276 271 261 165 138 20 619
Caroline Arous Switzerland 11 178 0.6× 193 0.7× 106 0.4× 88 0.5× 54 0.4× 15 384
Markus Jähnert Germany 15 154 0.6× 322 1.2× 226 0.9× 110 0.7× 125 0.9× 40 660
Jeanette Teague United States 9 266 1.0× 265 1.0× 74 0.3× 102 0.6× 142 1.0× 12 453
Nayara C. Leite Brazil 14 239 0.9× 152 0.6× 129 0.5× 144 0.9× 130 0.9× 27 511
Mark Lipsett Canada 16 620 2.2× 281 1.0× 127 0.5× 476 2.9× 483 3.5× 19 1.0k
Hisako Ohgawara Japan 16 629 2.3× 280 1.0× 72 0.3× 406 2.5× 344 2.5× 54 832
Cristina Mallol Spain 9 145 0.5× 176 0.6× 127 0.5× 136 0.8× 65 0.5× 11 394
Caroline Améen Sweden 13 167 0.6× 415 1.5× 99 0.4× 29 0.2× 79 0.6× 14 674
Galina Soukhatcheva Canada 13 325 1.2× 114 0.4× 92 0.4× 232 1.4× 137 1.0× 20 547
Takako Kakehi Japan 11 155 0.6× 306 1.1× 133 0.5× 63 0.4× 100 0.7× 14 467

Countries citing papers authored by Tadashi Hanabusa

Since Specialization
Citations

This map shows the geographic impact of Tadashi Hanabusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Hanabusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Hanabusa more than expected).

Fields of papers citing papers by Tadashi Hanabusa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Hanabusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Hanabusa. The network helps show where Tadashi Hanabusa may publish in the future.

Co-authorship network of co-authors of Tadashi Hanabusa

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Hanabusa. A scholar is included among the top collaborators of Tadashi Hanabusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Hanabusa. Tadashi Hanabusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasaki, Hideyuki, Tadashi Hanabusa, Hisao Wakasaki, et al.. (2012). Increased arterial stiffness is closely associated with hyperglycemia and improved by glycemic control in diabetic patients. Journal of Diabetes Investigation. 4(1). 82–87. 16 indexed citations
2.
Furuta, Machi, et al.. (2006). Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients. Diabetes Research and Clinical Practice. 72(3). 302–307. 15 indexed citations
3.
Nishi, Masahiro, Setsuya Sakagashira, Hiroto Furuta, et al.. (2004). Uncoupling Protein 2 Promoter Polymorphism −866G/A Affects Its Expression in β-Cells and Modulates Clinical Profiles of Japanese Type 2 Diabetic Patients. Diabetes. 53(2). 482–485. 88 indexed citations
4.
Nakagawa, Takayuki, Hiroto Furuta, Tokio Sanke, et al.. (2004). Molecular scanning of the betacellulin gene for mutations in type 2 diabetic patients. Diabetes Research and Clinical Practice. 68(3). 188–192. 2 indexed citations
5.
Ogawa, Kenichi, Hideyuki Sasaki, Hiroshi Yamasaki, et al.. (2004). History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy. Diabetes Research and Clinical Practice. 66. S165–S168. 14 indexed citations
6.
Hanabusa, Tadashi, et al.. (2004). Clinical Study for In/Yo (yin/yang), Kyo/Jitsu (xu/shi) in Patients with Type 2 Diabetes Mellitus. Kampo Medicine. 55(1). 125–129.
7.
Shono, Takeshi, Masato Kobayashi, Hisao Wakasaki, et al.. (2004). Neurosarcoidosis with Spinal Root Pain as the First Symptom. Internal Medicine. 43(9). 873–877. 11 indexed citations
9.
Shimomura, Hiroko, Hiroto Furuta, Masahiro Nishi, et al.. (2003). A rare case of autoimmune polyglandular syndrome type 3. Diabetes Research and Clinical Practice. 61(2). 103–108. 16 indexed citations
10.
Furuta, Hiroto, Machi Furuta, Tokio Sanke, et al.. (2002). Nonsense and Missense Mutations in the Human Hepatocyte Nuclear Factor-1β Gene (TCF2) and Their Relation to Type 2 Diabetes in Japanese. The Journal of Clinical Endocrinology & Metabolism. 87(8). 3859–3863. 44 indexed citations
11.
Hanabusa, Tadashi, Yoshio Nakano, Masahiro Nishi, et al.. (2001). The renal metabolism of insulin: Urinary insulin excretion in patients with mutant insulin syndrome (insulin Wakayama). Metabolism. 50(8). 863–867. 5 indexed citations
12.
Ogawa, Kenichi, Hideyuki Sasaki, Yutaka Kishi, et al.. (2001). A suspected case of proximal diabetic neuropathy predominantly presenting with scapulohumeral muscle weakness and deep aching pain. Diabetes Research and Clinical Practice. 54(1). 57–64. 4 indexed citations
13.
Shimajiri, Yoshinori, Tokio Sanke, Hiroto Furuta, et al.. (2001). A Missense Mutation of Pax4 Gene (R121W) Is Associated With Type 2 Diabetes in Japanese. Diabetes. 50(12). 2864–2869. 88 indexed citations
14.
Sakagashira, Setsuya, Henry J. Hiddinga, Kayoko Tateishi, et al.. (2000). S20G Mutant Amylin Exhibits Increased in Vitro Amyloidogenicity and Increased Intracellular Cytotoxicity Compared to Wild-Type Amylin. American Journal Of Pathology. 157(6). 2101–2109. 119 indexed citations
15.
Ohagi, Shinya, Tokio Sanke, Hiroto Furuta, et al.. (1998). Characterization of the Promoter of the Mouse Prohormone Convertase PC2 Gene.. Endocrine Journal. 45(4). 569–573. 2 indexed citations
16.
Sakagashira, Setsuya, Tokio Sanke, Tadashi Hanabusa, et al.. (1996). Missense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients. Diabetes. 45(9). 1279–1281. 124 indexed citations
17.
18.
Hanabusa, Tadashi, Shinya Ohagi, J LaMendola, Shu Jin Chan, & Donald F. Steiner. (1994). Nucleotide sequence and analysis of the mouse SPC3 promoter region. FEBS Letters. 356(2-3). 339–341. 5 indexed citations
19.
Hanabusa, Tadashi, et al.. (1992). Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice. 15(1). 89–96. 40 indexed citations
20.
Nishimura, Susumu, et al.. (1992). Lack of effect of islet amyloid polypeptide on hepatic glucose output in the in situ-perfused rat liver. Metabolism. 41(4). 431–434. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026